Medicare Enrolled
Dr. Megan Milne, MD
Rheumatology · New Bern, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Milne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Milne?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Milne
Dr. Megan Milne is a rheumatology specialist in New Bern, NC, with 9 years of NPI registration. Based on federal Medicare data, Dr. Milne performed 3,285 Medicare services across 1,537 unique beneficiaries.
Between the years covered by Open Payments, Dr. Milne received a total of $1,822 from 36 pharmaceutical and/or device companies across 91 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Milne is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ 3,285 Medicare services
$1,822 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,285
Medicare services
Bottom 42% in NC for rheumatology
1,537
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~365 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 900 | $19 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $87 | $247 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
320 | $8 | $12 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
241 | $8 | $24 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
137 | $10 | $32 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
135 | $1 | $6 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
123 | $3 | $10 |
| New patient office visit, complex (60-74 min) | 108 | $159 | $409 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
104 | $91 | $280 |
| Liver enzyme (SGPT) level test A blood test that measures the level of the liver enzyme SGPT to assess liver function. |
89 | $5 | $16 |
| Liver enzyme (SGOT) level test A blood test that measures the level of the liver enzyme SGOT to help assess liver health. |
88 | $5 | $16 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
87 | $5 | $16 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
87 | $5 | $16 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
58 | $19 | $54 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
58 | $104 | $314 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
50 | $20 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $133 | $349 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $11 | $40 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
35 | $6 | $20 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
28 | $29 | $100 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
28 | $4 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $68 | $175 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
16 | $27 | $95 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
15 | $13 | $42 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
14 | $6 | $18 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
14 | $5 | $16 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
13 | $9 | $28 |
| Iron level test | 12 | $6 | $20 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
11 | $2 | $10 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $54 | $206 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
34.2% medium
62.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,822
Total received (2022-2024)
Avg $607/year across 3 years
Bottom 39% in NC for rheumatology
36
Companies
91
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,806 (99.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$919
2023
$523
2022
$380
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$275
Lilly USA, LLC
$140
Amgen Inc.
$93
Radius Health, Inc.
$72
Lundbeck LLC
$55
E.R. Squibb & Sons, L.L.C.
$33
BANNER LIFE SCIENCES, LLC
$30
PFIZER INC.
$28
Fresenius Kabi USA, LLC
$25
Merck Sharp & Dohme LLC
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Grifols USA, LLC
$17
Novo Nordisk Inc
$17
Regeneron Healthcare Solutions, Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
VERTEX PHARMACEUTICALS INCORPORATED
$15
Actelion Pharmaceuticals US, Inc.
$14
Ardelyx, Inc.
$14
Organon Llc
$12
Top 3 companies account for 55.2% of 2024 payments
All-time payments by company (2022-2024) ›
ABBVIE INC.
$341
Lilly USA, LLC
$220
Amgen Inc.
$197
Horizon Therapeutics plc
$171
Radius Health, Inc.
$88
Lundbeck LLC
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
PFIZER INC.
$50
AstraZeneca Pharmaceuticals LP
$45
UCB, Inc.
$44
E.R. Squibb & Sons, L.L.C.
$33
Mallinckrodt Hospital Products Inc.
$32
BANNER LIFE SCIENCES, LLC
$30
Genentech USA, Inc.
$30
Grifols USA, LLC
$29
Alnylam Pharmaceuticals Inc.
$28
ARGENX US, INC.
$27
Amneal Pharmaceuticals LLC
$25
Fresenius Kabi USA, LLC
$25
Corium, LLC
$24
Merck Sharp & Dohme LLC
$23
Sandoz Inc.
$23
Janssen Biotech, Inc.
$20
Neurocrine Biosciences, Inc.
$20
Avanir Pharmaceuticals, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$18
Novo Nordisk Inc
$17
Regeneron Healthcare Solutions, Inc.
$17
Alexion Pharmaceuticals, Inc.
$16
Organon LLC
$16
Biohaven Pharmaceutical Holding Company Ltd.
$16
VERTEX PHARMACEUTICALS INCORPORATED
$15
Pharmacosmos Therapeutics Inc.
$14
Actelion Pharmaceuticals US, Inc.
$14
Ardelyx, Inc.
$14
Organon Llc
$12
Top 3 companies account for 41.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · AUSTEDO · BAFIERTAM · Briviact · Cimzia · DUPIXENT · EMGALITY · EVENITY · Enbrel · HADLIMA · HYRIMOZ · IBSRELA · KEYTRUDA · KRYSTEXXA · MONOFERRIC · MOUNJARO · NURTEC ODT · Nuedexta · OFEV · ONPATTRO · OPSUMIT · ORENCIA · Ongentys · Otezla · Ozempic · Prolastin-C Liquid · RENFLEXIS · RINVOQ · RYTARY · SAPHNELO · SKYRIZI · TALTZ · TREMFYA · Tymlos · ULTOMIRIS · VYEPTI · VYVGART · XELJANZ · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
4
Per 100K population
4.0
County median income
$64,635
Nearest hospital
CAROLINA EAST MEDICAL CENTER
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Milne is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Milne experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Milne performed 900 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Milne receive payments from pharmaceutical companies?
Yes. Dr. Milne received a total of $1,822 from 36 companies across 91 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Milne's costs compare to other rheumatologists in New Bern?
Dr. Milne's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Milne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in New Bern
Browse rheumatologists in New Bern ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NC
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NC
Which NC rheumatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology